121 related articles for article (PubMed ID: 11884289)
1. Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice.
Zhu B; Reardon CA; Getz GS; Hui DY
Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):450-5. PubMed ID: 11884289
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice.
Zhu B; Kuhel DG; Witte DP; Hui DY
Am J Pathol; 2000 Dec; 157(6):1839-48. PubMed ID: 11106557
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.
Moore ZW; Hui DY
J Lipid Res; 2005 Oct; 46(10):2083-90. PubMed ID: 16061951
[TBL] [Abstract][Full Text] [Related]
4. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice.
Schober A; Knarren S; Lietz M; Lin EA; Weber C
Circulation; 2003 Nov; 108(20):2491-7. PubMed ID: 14581398
[TBL] [Abstract][Full Text] [Related]
5. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of endothelial CXCR4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice.
Noels H; Zhou B; Tilstam PV; Theelen W; Li X; Pawig L; Schmitz C; Akhtar S; Simsekyilmaz S; Shagdarsuren E; Schober A; Adams RH; Bernhagen J; Liehn EA; Döring Y; Weber C
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1209-20. PubMed ID: 24723559
[TBL] [Abstract][Full Text] [Related]
7. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.
Zhang L; Hagen PO; Kisslo J; Peppel K; Freedman NJ
J Vasc Surg; 2002 Oct; 36(4):824-32. PubMed ID: 12368745
[TBL] [Abstract][Full Text] [Related]
8. Vascular apolipoprotein e expression and recruitment from circulation to modulate smooth muscle cell response to endothelial denudation.
Moore ZW; Zhu B; Kuhel DG; Hui DY
Am J Pathol; 2004 Jun; 164(6):2109-16. PubMed ID: 15161645
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
Zhu Y; Farrehi PM; Fay WP
Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
[TBL] [Abstract][Full Text] [Related]
10. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.
Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Lüscher TF; Chanson M; Kwak BR
Circulation; 2006 Jun; 113(24):2835-43. PubMed ID: 16769907
[TBL] [Abstract][Full Text] [Related]
11. Subphysiologic apolipoprotein E (ApoE) plasma levels inhibit neointimal formation after arterial injury in ApoE-deficient mice.
Wientgen H; Thorngate FE; Omerhodzic S; Rolnitzky L; Fallon JT; Williams DL; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1460-5. PubMed ID: 15178566
[TBL] [Abstract][Full Text] [Related]
12. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.
Krohn R; Raffetseder U; Bot I; Zernecke A; Shagdarsuren E; Liehn EA; van Santbrink PJ; Nelson PJ; Biessen EA; Mertens PR; Weber C
Circulation; 2007 Oct; 116(16):1812-20. PubMed ID: 17893273
[TBL] [Abstract][Full Text] [Related]
13. Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice.
Liehn EA; Schober A; Weber C
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1891-6. PubMed ID: 15331432
[TBL] [Abstract][Full Text] [Related]
14. Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice.
Zernecke A; Liehn EA; Fraemohs L; von Hundelshausen P; Koenen RR; Corada M; Dejana E; Weber C
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):e10-3. PubMed ID: 16306427
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of chlorinated and oxidized phospholipids in vascular tissue: implications for neointima formation.
Greig FH; Hutchison L; Spickett CM; Kennedy S
Clin Sci (Lond); 2015 May; 128(9):579-92. PubMed ID: 25524654
[TBL] [Abstract][Full Text] [Related]
16. Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient mice.
Li G; Sanders JM; Phan ET; Ley K; Sarembock IJ
Am J Pathol; 2005 Dec; 167(6):1511-8. PubMed ID: 16314466
[TBL] [Abstract][Full Text] [Related]
17. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
[TBL] [Abstract][Full Text] [Related]
18. Neointimal formation in two apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.
Shi W; Pei H; Fischer JJ; James JC; Angle JF; Matsumoto AH; Helm GA; Sarembock IJ
J Lipid Res; 2004 Nov; 45(11):2008-14. PubMed ID: 15314103
[TBL] [Abstract][Full Text] [Related]
19. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis.
Sanz-González SM; Barquín L; García-Cao I; Roque M; González JM; Fuster JJ; Castells MT; Flores JM; Serrano M; Andrés V
Cardiovasc Res; 2007 Sep; 75(4):803-12. PubMed ID: 17570351
[TBL] [Abstract][Full Text] [Related]
20. Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis.
Sawada Y; Onoda K; Imanaka-Yoshida K; Maruyama J; Yamamoto K; Yoshida T; Shimpo H
Cardiovasc Res; 2007 Jun; 74(3):366-76. PubMed ID: 17383619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
